[1]
A. P. Sari, M. Sidik, and S. Nusanti, “Outcome and Safety of Different Cumulative Doses and Protocols of Intravenous Methylprednisolone in Moderate to Severe and Active Graves’ Ophthalmopathy”, OI, vol. 43, no. 1, p. 15, Jan. 2019, doi: 10.35749/journal.v43i1.131.